Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Pharmacists Could Help Prevent Inappropriate Prescriptions For Older Adults: Study November 16, 2018 Martha Garcia Add Your Comments To protect elderly patients from medical mistakes or inappropriate prescriptions, a new study suggests that pharmacies could play an important role in reducing use of potentially harmful drugs. In a study published this week in the the Journal of the American Medical Association (JAMA), researchers found that “deprescribing” programs help to reduce inappropriate prescriptions by nearly 50%. Researchers from the Developing Pharmacist-Led Research to Educate and Sensitize Community Residents to the Inappropriate Prescriptions Burden in the Elderly (D-PRESCRIBE) study recruited community pharmacies in Quebec, Canada from February 2014 to September 2017 to participate in the program. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Nearly 500 patients were randomly selected to either be in an intervention group or control group. Patients were 65 years or older and taking one of four prescribed medications, including sedative-hypnotics, first-generation antihistamines, glyburide for diabetes, or nonsteroidal anti-inflammatory drugs (NSAIDs). Patients were recruited from 69 community pharmacies. Pharmacists were encouraged to send patients in the intervention group an educational brochure about the benefits of deprescribing, or beginning a protocol to stop or reduce prescriptions that may be harmful or no longer needed. They also sent the doctors of those patients information on evidence-based pharmaceutical opinion about deprescribing. The pharmacists in the control group provided the usual care to patients. The findings indicate that 43% of patients in the intervention group were able to discontinue an inappropriate medication after six months. Comparatively, 12% of patients in the non-intervention group discontinued inappropriate medications. Broken down by each category of medication, nearly half of the patients taking sedatives were able to discontinue medications they didn’t need or that were no longer appropriate. This is especially important among elderly patients. Sedatives can cause a person to experience drowsiness or dizziness, which may lead to a fall for an older adult. One-third of patients taking glyburide for type 2 diabetes stopped taking inappropriate medications and nearly 60% of NSAID users were able to stop taking inappropriate NSAIDS by the six month mark. Researchers noted the small sample size of antihistamine users prevented them from gathering complete data on those users. Furthermore, none of the patients who stopped taking inappropriate medications experienced side effects requiring hospitalization. Study authors warned, high rates of inappropriate prescribing persist among older adults. Nearly one-third of Medicare beneficiaries in the U.S. over the age of 65 have at least one inappropriate medication prescribed to them. In Canada, roughly 31% use inappropriately prescribed medications. Taking inappropriate medications that are no longer necessary can lead to avoidable and harmful side effects and drug-related hospitalizations. Many doctors refrain from taking patients off inappropriate medications for fear the patient may experience side effects or withdrawal. Some doctors indicate they simply don’t have time to safely step their patient down from the drugs. Researchers of the new study warn it is important to establish pharmacy programs to discourage patients from taking inappropriate medications and discourage doctors from prescribing inappropriate prescriptions. By launching these types of programs, it can help lead older patients to take fewer unnecessary or harmful prescriptions. Written by: Martha Garcia Health & Medical Research Writer Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers. Tags: Drug Side Effects, Medication Error, Pharmacy, Prescription Mistake More Lawsuit Stories Paraquat Lawsuits Over Parkinson’s Disease Continue To Be Filed, As MDL Stay Extended January 2, 2026 AngioDynamics Vortex Failure Led to Port Catheter Removal, Lawsuit January 2, 2026 Ford Vehicle Recalls Set New Record in 2025, Exceeding 150 Actions January 2, 2026 0 Comments CommentsThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Paraquat Lawsuits Over Parkinson’s Disease Continue To Be Filed, As MDL Stay Extended (Posted: today) Syngenta and Chevron continue to face a growing number of Paraquat lawsuits as the parties attempt to finalize a settlement agreement. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Parkinson’s Disease Settlement Payout Amounts Still Being Finalized (10/03/2025)Paraquat MDL Lawsuit Deadlines Extended Again, as Settlement Details Finalized (08/12/2025)Pesticide Exposure Could Lead to Higher Rheumatoid Arthritis Risks for Women Farm Workers: Study (07/23/2025) Sports Betting Problems Surge As More Americans Gamble Online, Survey Finds (Posted: 2 days ago) A new survey finds increasing rates in problem gambling throughout the state of Maryland since the legalization of mobile sports betting apps. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITClass Action Lawsuit Against FanDuel Seeks To Recover Losses for Californians (12/09/2025)Lawsuit Over DraftKings ‘No Risk’ Bet Promotions Cleared to Move Forward (11/25/2025)Lawsuit Over FanDuel, DraftKings Sports Betting Problems Returned to State Court (11/20/2025) Lawsuit Alleges Dupixent Caused Cancer Diagnosis After One Year of Injections (Posted: 3 days ago) A Dupixent lawsuit claims a woman developed T-cell lymphoma after just a year of injections, and must now receive lifelong medical monitoring. MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (12/19/2025)Lawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)
Paraquat Lawsuits Over Parkinson’s Disease Continue To Be Filed, As MDL Stay Extended January 2, 2026
Paraquat Lawsuits Over Parkinson’s Disease Continue To Be Filed, As MDL Stay Extended (Posted: today) Syngenta and Chevron continue to face a growing number of Paraquat lawsuits as the parties attempt to finalize a settlement agreement. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Parkinson’s Disease Settlement Payout Amounts Still Being Finalized (10/03/2025)Paraquat MDL Lawsuit Deadlines Extended Again, as Settlement Details Finalized (08/12/2025)Pesticide Exposure Could Lead to Higher Rheumatoid Arthritis Risks for Women Farm Workers: Study (07/23/2025)
Sports Betting Problems Surge As More Americans Gamble Online, Survey Finds (Posted: 2 days ago) A new survey finds increasing rates in problem gambling throughout the state of Maryland since the legalization of mobile sports betting apps. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITClass Action Lawsuit Against FanDuel Seeks To Recover Losses for Californians (12/09/2025)Lawsuit Over DraftKings ‘No Risk’ Bet Promotions Cleared to Move Forward (11/25/2025)Lawsuit Over FanDuel, DraftKings Sports Betting Problems Returned to State Court (11/20/2025)
Lawsuit Alleges Dupixent Caused Cancer Diagnosis After One Year of Injections (Posted: 3 days ago) A Dupixent lawsuit claims a woman developed T-cell lymphoma after just a year of injections, and must now receive lifelong medical monitoring. MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (12/19/2025)Lawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)